Search For "ph"
Glenmark releases interim data from PMS Study on Favipiravir (FabiFlu®
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 9 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India.
Read More
Jagan Reddy releases Rs 370 crores under phase 2 of Jagananna Thodu scheme
Updated : 4 years, 9 months ago IST
Amaravati (Andhra Pradesh) [India], June 8 (ANI): Andhra Pradesh Chief Minister YS Jagan Mohan Reddy on Tuesday released 370 crores under Phase 2 of the Jagananna Thodu scheme.
Read More
IREDA extends bid submission to June 15 for implementation of CPSU scheme
Updated : 4 years, 9 months ago IST
New Delhi [India], June 7 (ANI): Indian Renewable Energy Development Agency Limited (IREDA), a PSU under the Ministry of New and Renewable Energy (MNRE), has extended the bid submission date to June 15 for implementation of the Central Public Sector Undertaking (CPSU) scheme phase-II for set
Read More
Malta-based pharma firm offers to provide 60 million doses of Sputnik V to
Updated : 4 years, 9 months ago IST
Chandigarh [India], June 4 (ANI): The Haryana government on Saturday informed that it has received an "expression of interest" from a Malta-based pharma company to provide up to 60 million does of Sputnik V COVID-19 vaccine.
Read More
Gyms, spas, salons, bars, restaurants to remain closed in this Unlock phas
Updated : 4 years, 9 months ago IST
New Delhi [India], June 5 (ANI): As the Unlock phase commences from June 7 in Delhi, the Delhi government on Saturday informed that gyms, spas, salons, bars, restaurants will remain closed in the national capital, in view of the prevailing COVID-19 situation.
Read More
Centre caps prices of oxygen concentrators
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): The National Pharmaceutical Pricing Authority (NPPA) has capped the trade margin for oxygen concentrators at 70 per cent, the Ministry of Chemicals and Fertilizers said on Friday.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 4 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Theophylline Extended-release Tablets, 300 mg and 450 mg, bioequivalent and therapeutically equivalent
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
Vande Bharat Mission phase 2: First flight from Dubai to land today at Vij
Updated : 4 years, 9 months ago IST
Krishna (Andhra Pradesh) [India], June 2 (ANI): As part of the Vande Bharat Mission, international flights will resume their services from Wednesday onwards and the first flight from Dubai will land today at Vijayawada International Airport.
Read More
Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 2 (ANI): Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisit
Read More
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 4 years, 9 months ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 m
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 1 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel® Tablets, 200 mg and 400 mg of Eisai, Inc.
Read More